A new study reports inflammation in the blood may play a role in cognitive problems following chemotherapy. Researchers report identifying the inflammatory biomarkers and reducing inflammation may prevent some of the symptoms of chemo brain.
A new drug has been cleared for human trials in patients with anaplastic astrocytoma and glioblastoma brain cancers. The drug, PAC-1, is reported to spur cancer cells to self destruct and has proven to be effective in animal models of brain cancers.
Many breast cancer survivors report cognitive problems following treatment. New research from UCSD finds breast cancer survivors who increase physical activity and embark on regular exercise experience improved mental processing.